Glenmark Pharmaceuticals
GLENMARK.NS
#2815
Rank
NZ$7.55 B
Marketcap
$26.74
Share price
-4.24%
Change (1 day)
23.44%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.19

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.18. In 2022 the company made an earnings per share (EPS) of $0.65 a decrease over its 2021 EPS that were of $0.82.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.19-70.48%
2022$0.65-20.18%
2021$0.827.13%
2020$0.7625.72%
2019$0.61-22.01%
2018$0.7830.15%
2017$0.60-34.82%
2016$0.9263.09%
2015$0.569.68%
2014$0.51-26.58%
2013$0.700.51%
2012$0.70